Lymphoma, B-Cell, Marginal Zone

"Lymphoma, B-Cell, Marginal Zone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.

Descriptor ID	D018442
MeSH Number(s)	C04.557.386.480.150.570 C15.604.515.569.480.150.570 C20.683.515.761.480.150.570
Concept/Terms	Lymphoma, B-Cell, Marginal Zone Lymphoma, B-Cell, Marginal Zone MALT Lymphoma Lymphoma, MALT Lymphomas, MALT MALT Lymphomas Lymphoma of Mucosa-Associated Lymphoid Tissue Lymphoma of Mucosa Associated Lymphoid Tissue Mucosa-Associated Lymphoid Tissue Lymphoma Mucosa Associated Lymphoid Tissue Lymphoma Lymphoma, Mucosa-Associated Lymphoid Tissue Lymphoma, Mucosa Associated Lymphoid Tissue Marginal Zone B-Cell Lymphoma Marginal Zone B Cell Lymphoma

Below are MeSH descriptors whose meaning is more general than "Lymphoma, B-Cell, Marginal Zone".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, B-Cell [C04.557.386.480.150]
Lymphoma, B-Cell, Marginal Zone [C04.557.386.480.150.570]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, B-Cell [C15.604.515.569.480.150]
Lymphoma, B-Cell, Marginal Zone [C15.604.515.569.480.150.570]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, B-Cell [C20.683.515.761.480.150]
Lymphoma, B-Cell, Marginal Zone [C20.683.515.761.480.150.570]

Below are MeSH descriptors whose meaning is related to "Lymphoma, B-Cell, Marginal Zone".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, B-Cell, Marginal Zone".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, B-Cell, Marginal Zone" by people in this website by year, and whether "Lymphoma, B-Cell, Marginal Zone" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2006	2	0	2
2007	1	0	1
2009	0	1	1
2012	1	0	1
2013	1	0	1
2015	1	0	1
2020	1	0	1

Below are the most recent publications written about "Lymphoma, B-Cell, Marginal Zone" by people in Profiles.

Leonard N, Lal K, Luffman C, O'Donnell P, Jolley L, Belazarian L. Darier sign in a teenager with primary cutaneous marginal zone lymphoma. Pediatr Dermatol. 2021 Mar; 38(2):494-496.

View in: PubMed
Evans JA, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, Fisher DA, Foley K, Hwang JH, Jue TL, Lightdale JR, Pasha SF, Sharaf R, Shergill AK, Cash BD, DeWitt JM. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc. 2015 Jul; 82(1):1-8.

View in: PubMed
Rasouli J, Patel SA, Skovrlj B, Gologorsky Y, Mascitelli J, Petersen B, Caridi J. Primary extranodal marginal zone lymphoma involving the skull. J Clin Neurosci. 2014 Feb; 21(2):351-3.

View in: PubMed
Morgan EA, Yu H, Pinkus JL, Pinkus GS. Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody. Am J Clin Pathol. 2013 Feb; 139(2):220-30.

View in: PubMed
Ferreri AJ, Govi S, Pasini E, Mappa S, Bertoni F, Zaja F, Montalb?n C, Stelitano C, Cabrera ME, Giordano Resti A, Politi LS, Doglioni C, Cavalli F, Zucca E, Ponzoni M, Dolcetti R. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012 Aug 20; 30(24):2988-94.

View in: PubMed
Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM. Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011 Feb 03; 470(7332):115-9.

View in: PubMed
Anacak Y, Miller RC, Constantinou N, Mamusa AM, Epelbaum R, Li Y, Calduch AL, Kowalczyk A, Weber DC, Kadish SP, Bese N, Poortmans P, Kamer S, Ozsahin M. Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):315-20.

View in: PubMed
Hyatt BJ, Paull PE, Wassef W. Gastric oncology: an update. Curr Opin Gastroenterol. 2009 Nov; 25(6):570-8.

View in: PubMed
Guay HM, Mishra R, Garcea RL, Welsh RM, Szomolanyi-Tsuda E. Generation of protective T cell-independent antiviral antibody responses in SCID mice reconstituted with follicular or marginal zone B cells. J Immunol. 2009 Jul 01; 183(1):518-23.

View in: PubMed
Ferreri AJ, Assanelli A, Crocchiolo R, Dognini GP, Resti AG, Politi LS, Doglioni C, Cappio FC, Dolcetti R, Ponzoni M. Therapeutic management of ocular adnexal MALT lymphoma. Expert Opin Pharmacother. 2007 Jun; 8(8):1073-83.

View in: PubMed

People

Explore

Similar Concepts

Top Journals